Camilla Sylvest

Executive Vice President, Commercial Strategy & Corporate Affairs, Novo Nordisk

Camilla Sylvest joined Novo Nordisk in 1996 as trainee. From 1997 to 2008 Ms Sylvest had roles in headquarters and regions within pricing, health economics, marketing and sales effectiveness. In 2003, she was appointed vice president of sales and marketing effectiveness in Region Europe. From 2008 to 2015, Ms Sylvest headed up affiliates and business areas of growing size and complexity in Europe and Asia and in 2013 she was also appointed corporate vice president. In August 2015, Ms Sylvest was appointed senior vice president and general manager of Novo Nordisk’s Region China. In this role she was responsible for the company’s activities in China, Taiwan and Hong Kong. In October 2017, Ms Sylvest was promoted to executive vice president.

Ms Sylvest serves as member of the board of Danish Crown A/S, Denmark.

Ms Sylvest holds an MSc in Economics from University of Southern Denmark and an Executive MBA from Scandinavian International Management Institute.

Ms Sylvest is a Danish national, born November 1972.

最新記事

ヘルスとヘルスケア

人类预期寿命延长,解决肥胖问题对于实现健康老龄化至关重要

由于预期寿命增加、生育率长期下降,到2050年,全球近五分之一的人口年龄将在65岁及以上。我们在延长寿命方面取得了令人惊叹的进展,但研究表明,虽然英国近几代人活得更久,健康状况却比前几代人更差。这主要归因于肥胖、癌症、糖尿病、高血压、肺病和心脏病等慢性疾病。

2025年03月17日

世界経済フォーラムについて

エンゲージメント

  • サインイン
  • パートナー(組織)について
  • 参加する(個人、組織)
  • プレスリリース登録
  • ニュースレター購読
  • 連絡先 (英語のみ)

リンク

言語

プライバシーポリシーと利用規約

サイトマップ

© 2025 世界経済フォーラム